Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

PRKACA

RBC: PKA · Substrate: PKA sub ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Capivasertib99.70.64
Netarsudil96.60.68
Baricitinib90.90.62
Midostaurin79.80.50
Ponatinib70.90.53
Ruxolitinib45.50.59
Abrocitinib37.80.58
Darovasertib32.90.72
Pacritinib28.80.45
Defactinib23.70.45
Bosutinib22.40.55
Fostamatinib20.90.61
Brigatinib17.20.51
Gilteritinib17.00.51
Pralsetinib15.10.64

Known variants

Open in new tab